Eric Gehrie

Dr. Eric Gehrie, an associate director of transfusion medicine at Johns Hopkins, dives into the complexities of sickle cell disease and its implications for blood transfusion. He reveals how a single amino acid can affect patient outcomes. The conversation highlights the challenges of alloimmunization and the vital need for genetic and serological matching. Eric emphasizes the global scope of sickle cell management, touches on emerging treatments like gene therapy, and shares his passion for safety in transfusion practices, making for an engaging discussion.